At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...

Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 ...

Please provide your email address to receive an email when new articles are posted on . Interventional procedures with eye drops as an adjunct are slowly becoming the foundational therapy for glaucoma ...

Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

In Bihar, awareness about glaucoma is gradually increasing, and many eye hospitals now provide advanced treatment solutions based on the stage and type of the disease.

Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk factors for developing glaucoma ...

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk factors for developing glaucoma ...

Glaukos ( (GKOS)) has issued an update. Glaukos Corporation released an investor presentation in March 2026 outlining its strategy to transform glaucoma and keratoconus care through interventional, ...

Ahead of World Glaucoma Day on March 12, we spoke to respected ophthalmologist Dr Yavische Reddy about some common questions ...